Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia
Clinical trial NCT07278908 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07278908
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2028-12-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.